Preclinical CRO Market
Preclinical CRO Market Study by Bioanalysis & DMPK Studies, Toxicology/Testing, Compound Management, Chemistry, and Safety Pharmacology from 2024 to 2034
Analysis of Preclinical CRO Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Preclinical CRO Market Outlook (2024 to 2034)
As revealed in a new study by Fact.MR, the global preclinical CRO market size is valued at US$ 12.19 billion in 2024 and is forecasted to expand at a CAGR of 7.1% to reach a size of US$ 24.15 billion by the end of 2034.
Preclinical contract research organizations (CRO) have become a profitable business environment as doctors and scientists keep researching new drugs to fight a variety of diseases.
A preclinical CRO is a kind of support center offering expertise in research and development that becomes crucial in navigating a drug candidate through animal testing and advancing it into the clinical phase. The market is evaluated to have a further positive outlook as the medical sector develops new drugs to prevent and cure different chronic diseases.
Contact research organizations are becoming increasingly popular as more and more medical professionals are contacting them to provide clinical trial services for the pharmaceutical, biotechnology, and other medical device industries.
These organizations help in providing detailed trials to conclude how effective and efficient a drug is before it can be passed to the clinical phase, thus improving its trustworthiness and demand in the market.
Key Market Growth Drivers
- Rising prevalence of chronic diseases has pushed medical professionals to better understand these diseases and start working on different cures. These cures or drugs have to be tested thoroughly before they can be released into the market, thus driving CRO service demand.
- Sometimes, medical professionals and sponsors lack the suitable resources to conduct trials. CROs are equipped with advanced technologies to execute trials, and thus, drug manufacturers are increasingly relying on them for clinical trials.
- CROs help in clinical trials and reduce the workload of drug manufacturers, leaving medical professionals to focus on their work without taking any pressure about trials.
- Every medicine or drug has different components and uses and requires different resources to conduct clinical trials before it can enter the market. CROs already have all kinds of available resources in place, thereby driving their demand.
- To produce an application to commercialize a medicine in a country, the sponsor must undertake research in that country, which can be time-consuming and costly. However, a CRO with research facilities and the right personnel can get the job done faster, allowing companies to commercialize their medicine in different countries.
All these factors have driven substantial demand for CROs across different countries as new drugs keep entering the market, leading to the overall expansion of the global preclinical CRO market size.
- With world-class medical infrastructure, the United States is a leading market and is set to account for 76.9% share of the North American market by 2034.
| Report Attributes | Details |
|---|---|
| Preclinical CRO Market Size (2024E) | US$ 12.19 Billion |
| Forecasted Market Value (2034F) | US$ 24.15 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.1% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 8.5% CAGR |
| Brazil Market Value (2034F) | US$ 555 Million |
| North America Market Share (2024E) | 41.8% |
| Latin America Market Share (2034F) | 3.9% |
| Key Companies Profiled | Syneos Health; Labcorp; Premier Research; Eurofins Scientific; Parexel; Icon; Worldwide Clinical Trials; Medpace; Society for Clinical Research; Catalent Pharma Solutions |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Market Trends are Improving the Stance of CROs?
“Increase in Number of Biopharmaceutical Organizations”
Surge in the need for preclinical CRO services is being attributed to the ever-increasing number of biopharmaceutical companies across the world, particularly in developed and agricultural nations. Because small- and medium-sized biopharmaceutical companies typically lack the assets and knowledge required to conduct preclinical research, they are delegating these responsibilities to preclinical CROs.
“Increase in Chronic Diseases Driving Preclinical CRO Market Growth”
Increased prevalence of several chronic illnesses and gene-related disorders is a key concern worldwide. As a result, several biopharmaceutical and medical device firms have boosted their research investments to produce new and novel medications and technologies for the diagnosis, prevention, and treatment of chronic illnesses.
Preclinical CROs help biopharmaceutical and medical device businesses focus on their main operations by delivering solutions and services for drug and device research and development. As a result, fast growth and development of the biopharmaceutical sector on the back of rising cases of chronic diseases are expected to play a significant role in the expansion of the worldwide market for preclinical CROs.
“Growing Numbers of Life-saving Drugs Driving Need for Clinical Test Requirements”
Growing demand for new life-saving medications is driving up spending on preclinical research. Preclinical CROs play an important role in the development of novel pharmaceuticals and staging concepts for their commercialization.
The latest COVID-19 pandemic increased activities related preclinical CROs. COVID-19 was new to the world, and thus, preclinical research was critical during this time. As a result, several organizations and governments invested heavily in preclinical viral research.
What are the Limitations of Contract Research Organizations?
“Regulatory Changes and Quality Control Assurance Affecting Market Growth Trajectory”
Because the pharmaceutical and biotechnology sectors are heavily regulated, changes in regulatory requirements lead to significant challenges for contract research organizations. Adapting to new legislation and ensuring compliance with ever-changing standards is a tough and costly task.
Maintaining high-quality standards is critical while conducting research and clinical trials. To meet regulatory authorities' rigorous standards, CROs must consistently invest in quality control and assurance systems.
CROs also manage sensitive and proprietary information on behalf of their clients. This data covers both patient health information and clinical trial results. Given the growing threat of cyberattacks and data breaches, they need to safeguard their data while maintaining their privacy.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Evaluation
Why are CROs Thriving in the United States?
“High Number of Life Science Businesses in the Country”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 4.14 Billion |
| Growth Rate (2024 to 2034) | 6% CAGR |
| Projected Value (2034F) | US$ 7.4 Billion |
The United States has several life science enterprises that are adopting clinical research services. CROs that provide these services are in high demand as technology developments such as telemedicine and virtual trials become increasingly widespread.
Drug development activities by biotech and pharmaceutical corporations are rising in the United States. These companies are increasingly relying on CROs for support, such as access to equipment and services for patients, enrolment and recruitment data, individualized protocol design, improved trial completion rates, and cheaper costs.
What's Improving the Market Environment in Brazil for Preclinical CROs?
“Government Making Regulatory Approval Process Easier”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 225 Million |
| Growth Rate (2024 to 2034) | 9.4% CAGR |
| Projected Value (2034F) | US$ 555 Million |
The clinical research organization business in Brazil is rising due to a variety of causes. Increasingly aging and rising population is a big contributing factor, driving the demand for cutting-edge medical cures and treatments. Furthermore, recent government reforms and policies have simplified the process of conducting clinical trials and research in the country.
Authorities have implemented several measures to expedite the regulatory clearance process for innovative drugs and cures, enticing global corporations to move their research and development activities to the country. Furthermore, evolution of healthcare and growing wealth levels in Brazil have increased the demand for sophisticated healthcare services, making clinical research even more attractive.
Category-wise Insights
Which Key Type of Service is Providers by CROs to Drug Manufacturers?
“Drug Development Key as They Possess Advanced Medical Equipment”
| Attribute | Drug Development Services |
|---|---|
| Segment Value (2024E) | US$ 4.71 Billion |
| Growth Rate (2024 to 2034) | 6.9% CAGR |
| Projected Value (2034F) | US$ 9.16 Billion |
After detailed research and analysis, a variety of drug manufacturers opt to hire a CRO to develop their drugs based on their research. The primary reason for this is due to advanced medical tools available with CROs that can help the process of drug development more ahead faster. The process of getting approval also gets expedited, thus helping drug manufacturers to introduce the drug into the market sooner.
Which Companies Look for CROs to Assist Them With Clinical Trials?
“Biopharmaceutical Companies Key Clients of CROs for Drug Development and Clinical Trials”
| Attribute | Biopharmaceutical Companies |
|---|---|
| Segment Value (2024E) | US$ 5.55 Billion |
| Growth Rate (2024 to 2034) | 8.5% CAGR |
| Projected Value (2034F) | US$ 12.52 Billion |
Biopharmaceuticals are complex medicines made from living cells or organisms. These medicines are often produced using cutting-edge biotechnological methods. Such medicines have to be efficiently tested before they are introduced into the market to the final user. Thus, professionals always look for an expert CRO in this field to work with clinical trials to conclude whether the medicine is fit to enter the market for consumption.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Market Landscape
Fast deployment of advanced healthcare technology for better medical care is one of the key factors fueling rivalry in the market. To retain their market share and broaden their product line, major corporations are exploring combinations as well as introducing novel products.
Key players in the preclinical CRO market are seeking to provide different services to address the evolving preclinical CRO market trends, including preclinical brain imaging and optical preclinical imaging.
- Editas Medicine reported in January 2021 that it had acquired FDA clearance for an Investigational New Drug (IND) Application for EDIT-301, which is used to treat transfusion-dependent beta-thalassemia.
Key Segments of Preclinical CRO Market Research
-
By Service :
- Bioanalysis & DMPK Studies
- Toxicology Testing
- Compound Management
- Chemistry
- Safety Pharmacology
-
By End Use :
- Biopharmaceutical Companies
- Government & Academic Institutes
- Medical Device Companies
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Service
- 9.1. Bioanalysis & DMPK Studies
- 9.2. Toxicology Testing
- 9.3. Compound Management
- 9.4. Chemistry
- 9.5. Safety Pharmacology
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End Use
- 10.1. Biopharmaceutical Companies
- 10.2. Government & Academic Institutes
- 10.3. Medical Device Companies
- 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 17. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 18. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 19. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Syneos Health
- 21.2. Labcorp
- 21.3. Premier Research
- 21.4. Eurofins Scientific
- 21.5. Parexel
- 21.6. Icon
- 21.7. Worldwide Clinical Trials
- 21.8. Medpace
- 21.9. Society for Clinical Research
- 21.10. Catalent Pharma Solutions
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Service
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End Use
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Service, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Service, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Service, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Service, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Service, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By End Use, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By End Use, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Service, 2024 (E)
Figure 18: North America Market Value Share, By End Use, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Service, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Service, 2024 (E)
Figure 26: Latin America Market Value Share, By End Use, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Service, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Service, 2024 (E)
Figure 34: Europe Market Value Share, By End Use, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Service, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Service, 2024 (E)
Figure 42: South Asia Market Value Share, By End Use, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Service, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Service, 2024 (E)
Figure 50: East Asia Market Value Share, By End Use, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Service, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Service, 2024 (E)
Figure 58: Oceania Market Value Share, By End Use, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Service, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Service, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By End Use, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Service, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Service, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By End Use, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Service, 2024 (E)
Figure 78: Canada Market Value Share, By End Use, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Service, 2024 (E)
Figure 81: Mexico Market Value Share, By End Use, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Service, 2024 (E)
Figure 84: Brazil Market Value Share, By End Use, 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Service, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By End Use, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Service, 2024 (E)
Figure 90: Germany Market Value Share, By End Use, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Service, 2024 (E)
Figure 93: France Market Value Share, By End Use, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Service, 2024 (E)
Figure 96: Italy Market Value Share, By End Use, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Service, 2024 (E)
Figure 99: Spain Market Value Share, By End Use, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Service, 2024 (E)
Figure 102: Russia Market Value Share, By End Use, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Service, 2024 (E)
Figure 105: China Market Value Share, By End Use, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Service, 2024 (E)
Figure 108: Japan Market Value Share, By End Use, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Service, 2024 (E)
Figure 111: South Korea Market Value Share, By End Use, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Service, 2024 (E)
Figure 114: India Market Value Share, By End Use, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Service, 2024 (E)
Figure 117: ASEAN Market Value Share, By End Use, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Service, 2024 (E)
Figure 120: Australia Market Value Share, By End Use, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Service, 2024 (E)
Figure 123: New Zealand Market Value Share, By End Use, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Service, 2024 (E)
Figure 126: GCC Countries Market Value Share, By End Use, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Service, 2024 (E)
Figure 129: Turkey Market Value Share, By End Use, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Service, 2024 (E)
Figure 132: South Africa Market Value Share, By End Use, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the preclinical research organization market?
The global preclinical research organization market is estimated at US$ 12.19 billion in 2024.
What is the projected global market size for 2034?
The market for preclinical CROS is forecasted to attain a value of US$ 24.15 billion by 2034.
Who are the key players in the preclinical CRO market?
Key players in the market are Syneos Health, Labcorp, and Premier Research.
What is the expected CAGR for the preclinical CRO market?
The market is foreseen to expand at a CAGR of 7.1% between 2024 and 2034.
What is the market share of North America in 2024?
North America is expected to account for 41.8% of the global market share in 2024.
How is Chile expected to perform in the preclinical CRO market?
The market in Chile is projected to expand at a CAGR of 8.4% between 2024 and 2034.
Preclinical CRO Market